Physician profile
Travis Desa
NPI 1902298219
$12,519.96
in general payments reported to CMS, 2019-2025
26 companies · $1,722 in 2025
The $1,722 reported for 2025 was more than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $146 · 2022: $491 · 2023: $2,403 · 2024: $7,758 · 2025: $1,722.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $7,196 · Travel and Lodging: $4,686 · Education: $1.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $7,195.97 |
| Travel and Lodging | $4,685.91 |
| Education | $1.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Edwards Lifesciences Corporation | $2,556.60 | 2022-2025 | Pascal, Edwards Sapien 3 Transcatheter Heart Valve (Thv), Edwards Sapien 3 Ultra Transcatheter Heart Valve |
| Abbott Laboratories | $1,773.65 | 2023-2025 | Amplatzer Amulet, Coroflow, Dragonfly Opstar |
| Medtronic, INC. | $1,566.71 | 2022-2025 | Corevalve Evolut R, Resolute Onyx, Selectsecure |
| Boston Scientific Corporation | $1,553.66 | 2023-2025 | Versacross Access Solution, Avvigo Guidance System, Comet |
| Inari Medical, INC. | $1,335.75 | 2024 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Shockwave Medical, INC | $830.58 | 2022-2024 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter, Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Abiomed | $717.78 | 2023-2025 | Impella |
| Penumbra, INC. | $412.64 | 2023-2024 | Indigo System |
| Heartflow, INC. | $256.22 | 2023 | Ffrct |
| Pfizer INC. | $211.95 | 2021-2022 | |
| Acist Medical Systems, INC. | $195.37 | 2023-2025 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $163.69 | 2023-2025 | Lifevest |
| W. L. Gore & Associates, INC. | $151.32 | 2023 | Gore Viabahn Endoprosthesis With Heparin |
| Merck Sharp & Dohme LLC | $146.06 | 2025 | Verquvo, Capvaxive |
| Teleflex LLC | $128.58 | 2023 | Manta |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bayer Healthcare Pharmaceuticals INC. | $128.51 | 2025 | |
| Chiesi USA, INC. | $90.02 | 2023-2024 | Kengreal, Cleviprex |
| Boehringer Ingelheim Pharmaceuticals, INC. | $82.52 | 2025 | Jardiance |
| Amgen INC. | $40.52 | 2023-2025 | Repatha |
| Alnylam Pharmaceuticals INC. | $35.30 | 2025 | Amvuttra |
| Novartis Pharmaceuticals Corporation | $29.23 | 2025 | |
| Novo Nordisk INC | $27.26 | 2025 | Wegovy |
| Scpharmaceuticals INC. | $27.11 | 2025 | |
| Canon Medical Systems USA, INC. | $23.62 | 2024 | Interventional Angiography System |
| Kestra Medical Technology Services, INC. | $19.79 | 2023 | Assure Wcd |
| Astrazeneca Pharmaceuticals LP | $15.52 | 2025 | Farxiga |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Travis Desa listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.